In short. There is no approved procedure called facial balancing. Each substance and device in the plan carries its own approval, and the plan is a clinical judgement.
Key points
- Approval and evidence are separate questions throughout this cluster.
- A plan can rest on sound reasoning and carry no approval whatever.
- What it cannot do is borrow a component approval and present that as covering the plan, which is the most common way the two are conflated in this category.
Regulation in this category works substance by substance, and there is no level at which a balancing plan is approved. Understanding why makes it clear what an approval claim does and does not cover.
What each component carries
A hyaluronic acid filler is approved for the correction of a defined facial area or a defined deficiency, in a defined market. A botulinum toxin product is approved for a defined set of muscle-related indications. A device is approved for a specific endpoint. Each of those approvals is narrow, each belongs to a product rather than to a category, and each was granted on the evidence the regulator was given for that indication.
Why the plan has no approval
A plan is not a product, an indication or a claim that a regulator can review. It is a selection of treatments made for one person, and there is nothing to label or to clear. The absence of approval is therefore not a comment on whether the plan is reasonable; it is a statement that the plan is not the kind of thing approval applies to. What approval does tell a reader is what each component was cleared for, which is a narrower and more useful fact than the sentence usually built on it.
No approval is not the same as no evidence
Approval and evidence are separate questions throughout this cluster. A plan can rest on sound reasoning and carry no approval whatever. What it cannot do is borrow a component approval and present that as covering the plan, which is the most common way the two are conflated in this category.
The aesthetic judgement is unregulated
No regulator approves an appearance, and none could. Whether a face reads as balanced, harmonious or natural is a judgement made by observers and by the person, and no validated instrument measures it. That has a practical consequence for a reader: the part of a balancing claim that carries the most weight in a consultation is the part with no regulatory or measurable basis at all, which is precisely why the reasoning behind each treated area is worth hearing in words.
Approval claims that do not hold
- A substance approval presented as covering the plan as a whole.
- An approval for a defined indication described as an approval for a look.
- A clearance in one market described as though it applied to the plan everywhere.
Reported separately, approval and judgement are both informative. Merged into one sentence, they are neither.
Frequently asked questions
Is a facial balancing plan approved by a regulator?
No. Regulators approve substances and devices for defined indications. A plan that selects several of them for one face is not a product and not an indication, so nothing approves it as a whole. The plan is a clinical judgement and the responsibility for it sits with the clinician who made it.
What is each substance in a plan approved for?
Its own indication, in its own market. A hyaluronic acid filler is approved for the correction of a defined area or deficiency, a botulinum toxin product for a defined set of muscle-related indications. Those approvals are specific and none of them extends to the plan that combined them.
Does an approval cover how a face looks afterwards?
No. No regulator approves an appearance. Approval covers a substance and an indication, and whether a face reads as balanced or natural afterwards is an aesthetic judgement that belongs to the observer and to the person. That is why an approval claim in this category describes something much narrower than the sentence around it.
Risks & Limitations
- Facial balancing is not a procedure and nothing is approved under that name; it is a frontal assessment and a plan drawn from it.
- No face is symmetrical and none needs to be, and a departure from the classical proportions is a description rather than a defect.
- Risk grows with every zone a plan treats, and it accumulates rather than averaging out across the plan.
- Whether a face reads as balanced or natural is a judgement; no validated instrument measures it and no regulator approves an appearance.
- A filler changes soft tissue and does not reshape bone, and a claim of skeletal restoration has no approval behind it.
When to Seek Care
- Severe pain, or skin that becomes dusky, mottled or pale after an injection — seek emergency care immediately.
- A change in vision, or pain around the eye, after any injection to the face — seek emergency care immediately.
- A fever with spreading redness, or a lump that is painful and enlarging, is assessed by a clinician rather than watched.
- A finding that appears suddenly, or a change in the position of the brow or mouth, is assessed by a clinician rather than treated.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — approved dermal fillers and their labelled indications
- National Medical Products Administration (NMPA, China) — approved products and their indications
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews of dermal fillers and facial volumising
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a plan or treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.